L&C BIO revenue breakdown overview

L&C BIO revenue for the last year amounted to 74.70 B KRW, the most of which — 56.87 B KRW — came from its highest performing source at the moment, Human Tissue Products, the year earlier bringing 53.76 B KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought L&C BIO 67.51 B KRW, and the year before that — 64.93 B KRW.